The prevalence of dyslipidemia by new guidelines NCEP-ATP III in Korean type 2 diabetic patients

被引：0
作者：
Kim, DK
Park, MK
Kang, DY
Lee, HJ
机构：
来源：
DIABETES | 2002年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2035
引用
收藏
页码：A495 / A495
页数：1
相关论文
共 50 条
[21]   Part 2 of 2 - Update on dyslipidemia management: Overview of the NCEP Adult Treatment Panel III guidelines [J].
Sanoski, CA .
FORMULARY, 2001, 36 (07) :518-521
[22]   Comparison of the NCEP ATP III and WHO definitions of the metabolic syndrome for predicting coronary artery calcification in asymptomatic type 2 diabetic patients [J].
Dhakshinamurthy, VA ;
Lim, ET ;
Lahiri, A ;
Hopkins, D ;
Lipkin, D .
CIRCULATION, 2005, 112 (17) :U792-U792
[23]   NCEP-ATP-III defined metabolic syndrome, type 2 diabetes mellitus and prevalence of hypogonadism in male patients with sexual dysfunction [J].
Corona, G. ;
Mannucci, E. ;
Petrone, L. ;
Belercia, G. ;
Paggi, F. ;
Fisher, A. D. ;
Lotti, F. ;
Chiarini, V ;
Forti, G. ;
Maggi, M. .
JOURNAL OF SEXUAL MEDICINE, 2008, 5 :89-90
[24]   NCEP-ATP III guidelines may underestimate the need for statin therapy in at-risk individuals: A cross-sectional 64-slice MDCT study [J].
Garg, Pankai ;
Zynda, Todd ;
Mosiuc, Florin ;
Khattar, Ramni ;
Malik, Shaista ;
Saremi, Farhood ;
Narula, Jagat ;
Gurudevan, Swaminatha .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) :A144-A145
[25]   Comparison of diagnostic criteria and prevalence of metabolic syndrome using WHO, NCEP-ATP III, IDF and harmonized criteria: A case study from urban southeast Nigeria [J].
Nwankwo, Monday ;
Okamkpa, Chikezie Jude ;
Danborno, Barnabas .
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2022, 16 (12)
[26]   Prevalence of diabetic nephropathy in primary care type 2 diabetic patients with hypertension: data from the Korean Epidemiology Study on Hypertension III (KEY III study) [J].
Yang, Chul-Woo ;
Park, Jung Tak ;
Kim, Yon Su ;
Kim, Yong Lim ;
Lee, Yil-Seob ;
Oh, Yoon-Sun ;
Kang, Shin-Wook .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (10) :3249-3255
[27]   2013 ACC/AHA VERSUS 2004 NCEP ATP III GUIDELINES IN THE PREDICTION OF CORONARY ARTERY CALCIFICATION PROGRESSION IN A KOREAN POPULATION [J].
Jung, C. H. ;
Kim, S. ;
Lee, W. J. ;
Park, J. Y. ;
Park, C. Y. .
ATHEROSCLEROSIS, 2016, 252 :E216-E216
[28]   Poor achievement of NCEP III lipid targets in type 2 diabetic patients: The Belgian OCAPI Study [J].
Scheen, AJ ;
van Gaal, LF .
DIABETES, 2002, 51 :A496-A497
[29]   The prevalence and risk factors associated with dyslipidemia in type 2 diabetic patients in the autonomous Region of Cantabria [J].
Diaz Vera, Alcibiades Segundo ;
Abellan Aleman, Jose ;
Segura Fragoso, Antonio ;
Martinez de Esteban, Juan Pablo ;
Lameiro Couso, Francisco Javier ;
Golac Rabanal, Miladi del Socorro ;
Diaz Vera, Luis Alberto ;
Matta Solis, Hernan Hugo .
ENDOCRINOLOGIA DIABETES Y NUTRICION, 2020, 67 (02) :102-112
[30]   TREATMENT OF DYSLIPIDEMIA IN DIABETIC TYPE 2 PATIENTS WITH HYPERTENSION [J].
Maglapheridze, Zviadi ;
Tabukashvili, Revaz ;
Kapetivadze, Vera ;
Tchaava, Khatuna ;
Gegeshidze, Nino ;
Lazashvili, Tamar ;
Grigorashvili, Zurab .
ATHEROSCLEROSIS, 2017, 263 :E217-E217
12345